Invention Grant
- Patent Title: Colon and pancreas cancer peptidomimetics
-
Application No.: US14725477Application Date: 2015-05-29
-
Publication No.: US09718866B2Publication Date: 2017-08-01
- Inventor: Xue-Ping Wang
- Applicant: PRECISION BIOLOGICS, INC.
- Applicant Address: US MD Rockville
- Assignee: Precision Biologics, Inc.
- Current Assignee: Precision Biologics, Inc.
- Current Assignee Address: US MD Rockville
- Agency: LeClairRyan, a professional corporation
- Agent Robin L. Teskin
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K39/00 ; A61K45/06 ; A61K47/48 ; C07K16/30 ; G01N33/574 ; A61K38/00
Abstract:
The invention relates to a peptidomimetic of an NPC-1 epitope on the MUC5AC protein which is differentially expressed in pancreatic and colorectal cancer, and diagnostic and therapeutic usages. Further, antibodies that selectively bind the NPC-1 epitope peptidomimetics and may be used in diagnostic and therapeutic methods.
Public/Granted literature
- US20150337023A1 Colon and Pancreas Cancer Peptidomimetics Public/Granted day:2015-11-26
Information query
